Skip to content

Performance of GP73 for diagnosing NASH in population with NAFLD

Performance of GP73 for diagnosing NASH in population with NAFLD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015157
Enrollment
Unknown
Registered
2018-03-11
Start date
2018-05-10
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease

Interventions

Gold Standard:The diagnosis of NAFLD is based on AASLD guideline(2012), including imaging examination and liver biopsy ("gold-standard")
Index test:1.&#32
and&#32
examination
2.&#32
serum&#32
GP73&#32

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients with clinically diagnosing NAFLD by imaging Technics, NAFLD diagnosis compliance with AASLD guideline of NAFLD (2012); 2. patients without receiving drug therapy for NAFLD; 3. willing to receive liver biopsy and histopathology examination, and related clinical lab test; 4. Writing Informed Consent Form, and take part in clinical research; 5. Aged 18-65 yaars old.

Exclusion criteria

Exclusion criteria: 1. all kinds chronic liver diseases, included but not limited to virus hepatitis, alcohol liver disease,drug-induced liver diseases, autoimmune liver diseases(included AIH,PBC,and PSC), and congenital liver diseases; 2. secondary to system diseases, included but not limited to all kinds of autoimmune diseases, and the liver is invovled; 3. all kinds of cancer, included hepatocellular cancinoma; 4. Existing contradiction of liver biopsy, or refusing receiving liver biopsy and histopathology; 5. company of heart,liver, lung, kidney failure,or abnormal function; 6. patients with other liver diseases, confirmed by liver pathological diagnosis.

Design outcomes

Primary

MeasureTime frame
GP73;liver biopsy and pathological diagnosis;

Countries

China

Contacts

Public ContactHongshan Wei

Beijing Ditan Hospital, Capital Medical University

drwei@ccmu.edu.cn+86 13810033129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026